Skip to main content
. 2019 Feb 4;8(3):194–198. doi: 10.4103/eus.eus_59_18

Table 4.

Adverse events

n (%) PPI group Non-PPI group P
GI bleeding 12 (4.4) 5 7 0.79
Infection 24 (8.8) 8 16 0.13
Stent occlusion 41 (15.0) 13 28 0.012
Stent migration 13 (4.7) 10 3 0.056

PPI: Proton pump inhibitors, GI: Gastrointestinal